Blogarama: The Oldest Blog Directory

Empresa. Pharma Mar S.A.Sector En  fondo del mar, matarile.Fecha análisis. Julio 2013.Empresa: www.pharmamar.comFuntes: Datos CNMVHey ¡¿Cómo estamos… Read More

Single User License: 5,195 USD Multi User License: 8,195 USDCorporate License: 11,195 USD Buy Now Request Sample Request Customization Marine Biotechnolo… Read More

Single User License: 5,195 USD Multi User License: 8,195 USDCorporate License: 11,195 USD Buy Now Request Sample Ask an Analyst Report SummaryFree AnalysisTable o… Read More

La farmacéutica española PharmaMar ha anunciado que los resultados de los estudios in vitro del fármaco Aplidin (plitidepsina) en el coronavirus humano HCoV-229E, que se… Read More

Los genomas oceánicos enfrentan amenazas, lo que pone en peligro su uso en los casos conocidos y en potenciales avances científicos y comerciales. El océano … Read More

The U.S. FDA approved Jazz Pharmaceuticals and its partner PharmaMar’s Zepzelca (lurbinectedin) for adults with metastatic small cell lung cancer (SCLC) whose disease has progressed on… Read More

– Bought Deal-Angebot von 6,9 Mio. $ mit vollständiger Ausübung von Überzuteilungsoption – Überzeichnete, nicht vermittelte Privatplatzierung in Höhe vo… Read More

O medicamento em causa age bloqueando uma proteína humana (a eEF1A) que está presente nas células e que é usada pelo novo coronavírus para se reproduzir e… Read More

Similar to previous years, 2020 also proved overall to be a successful year for drug approvals despite the COVID-19 pandemic. For the Food and Drug Administration (FDA), the number of ap… Read More

13 Anti-tumor drugs Trastuzumab deruxtecan (Enhertu), an antibody drug conjugate (ADC) developed by Japan’s Daiichi Sankyo and authorized by AstraZeneca for co-development and comme… Read More

Plitidepsin was originally obtained from a kind of protozoans, called Aplidiumalbicans. Plitidepsin, also known as dehydrodidemnin B, is a member of the class of compounds known as didemnins… Read More

This article PharmaMar announces the IDMC’s response on the CORAIL trial using PM1183 appeared first on Project Topics. Madrid, August 11th, 2016 – PharmaMar (MSE:PHM) announces… Read More

This article PharmaMar announces the signature of a Memorandum of Understanding with the Indonesian Oceanographic Research Center to address the fight against cancer appeared first on Projec… Read More

This article PharmaMar and Chugai agree to terms for early termination of the agreement for Zepsyre in Japan appeared first on Project Topics. Madrid, 26th of June 2018.- On April 27th, 2018… Read More

This article PharmaMar presents at ASCO the ADMYRE study’s adjusted overall survival with plitidepsin appeared first on Project Topics. Abstract #8018 PharmaMar presents in oral sessio… Read More

This article Positive recommendation IDMC to Zepsyre® to continue Phase III trial small-cell lung cancer appeared first on Project Topics. (Pharmamar) PharmaMar has announced today that… Read More

This article PharmaMar announces data presentations: Yondelis® and lurbinectedin at ASCO appeared first on Project Topics. (Pharmamar) During the Congress of the American Society of Clin… Read More

This article PharmaMar discovers new data on the mechanism of action of plitidepsin in tumor cells appeared first on Project Topics. Credit: @PharmaMar 2018 PharmaMar (MSE: PHM) has presente… Read More

This article PharmaMar’s lurbinectedin ATLANTIS trial in SCLC will be an oral presentation appeared first on Project Topics. Dr. Anna Farago, oncologist form the Massachusetts General… Read More

This article PharmaMar presents positive results from a Phase II study of PM1183 in Ewing’s sarcoma appeared first on Project Topics. (Pharmamar) PharmaMar (MSE:PHM) has presented posi… Read More

This article PharmaMar and Boryung Pharm sign a licensing agreement for Zepsyre in Korea appeared first on Project Topics. Madrid, November 7th, 2017 – PharmaMar (MSE:PHM) has announce… Read More

This article The WHO selects Tivanisiran as the international nonproprietary name for SYL1001 appeared first on Project Topics. Sylentis, a Pharmaceutical Company of PharmaMar Group (MCE: PH… Read More

This article PharmaMar starts clinical studies with a new compound -PM14- in patients with solid tumors appeared first on Project Topics. After its preclinical phase, where the compound has… Read More

This article New data on PM1183 sees a response rate of 36 percent as single agent in patients with SCLC appeared first on Project Topics. Madrid, September 12th, 2017.- PharmaMar (MSE:PHM)… Read More

This article PharmaMar starts a quadruple combination study with Aplidin for the treatment of multiple myeloma appeared first on Project Topics. Aplidin® is an ideal compound for combini… Read More

This article PharmaMar will commercialize PM1183 with the trade name of Zepsyre™ appeared first on Project Topics. (Pharmamar) PharmaMar (PHM:MSE) has announced that PM1183 (lurbinected… Read More

This article PharmaMar to host research and development event on April 24, 2017 appeared first on Project Topics. The event will be hosted by members of PharmaMar’s senior management t… Read More

12 de Enero - La compañía PharmaMar ha anunciado este martes la publicación de un estudio sobre la actividad in vitro de Aplidín, fármaco en desarrollo con… Read More

(NaturalNews) (Natural News) Jose Maria Fernandez Sousa-Faro, president of the European pharmaceutical giant PharmaMar, was outed for falsifying his Wuhan coronavirus (COVID-19) “vacc… Read More

Big Pharma President CAUGHT With FAKE VAX PASSPORT! The President of a big pharma company, PharmaMar, was one of 2,200 people caught with fake vaccination papers by Spanish police. All of… Read More

Rapture Ready End Times News 11 Jun 2022 Published on: June 11, 2022 by RRadmin7 3 US Companies That Allegedly Sent Defense Blueprints To China Receive Export Denial Order On June 7, the Com… Read More

Έπεσαν μονοί τους στην παγίδα του&si… Read More

Telephone For the telecommunications operator, we have the change in Barclays bias, which puts black on white, and changes, in just 15 days, the valuation of the company. In fact, it raise… Read More

In the video, we analizamos los siguientes valores desde the point of view of technical analysis: Acciona (MC:); ACS (MC:); CIE Automotive (MC:); Endesa (MC:); Grifols (MC:); Iberdr… Read More

Logista busca su última oportunidad de entrar en el Ibex 35 este año. La compañía se ha situado entre las aspirantes a formar parte del índice a lo largo d… Read More

PharmaMar entró a formar parte del Ibex en el mes de septiembre de 2020, y dos años después, tras perder más de un 30% en bolsa, se juega salir del índice… Read More

A landmark trial In June 2019, PharmaMar presented the results of the second phase of the lurbinectedin trial at the American Society of Clinical Oncology (ASCO) meeting in Chicago. The stud… Read More

 The marine biotechnology market would grow at a CAGR of 7.09% over the predicted time frame. The market is expected to increase in value from US$ 5.9 Bn in 2022 to US$ 11.7 B… Read More

The post North America IoT in Renewable Energy Market Size 2026 appeared first on Newstrail.com authored by Maximize Market Research  North America IoT in Renewable Energy Mar… Read More

Global Marine Biotechnology Market Set for Impressive Growth in the Forecast Period According to a report by TechSci Research titled “Marine Biotechnology Market – Global Indu… Read More

The post Marine Biotechnology Market  was valued at USD 8.67 Bn. grow at a CAGR of 6.2% in 2029. appeared first on Newstrail.com authored by Maximize Market Research Marine Biotech… Read More

The marine biotechnology market size is poised to grow by $ 11.7 billion by 2032 from $ 5.9 billion in 2022, exhibiting a CAGR of 7.09% during the forecast period 2023-2032.  The Marin… Read More

Marine biotechnology market projected to reach $5.79 billion by 2023, driven by demand for eco-friendly energy systems. Marine insurance market expected to reach $40.5 billion by 2028, fuel… Read More

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Malignant Pleural Mesothelioma pipeline constitutes 20+ key companies continuously working towards deve… Read More